Wednesday, January 27, 2016

Philips company

'Health care' of Philips comparable sales have grown three percent between September and December 2015 on the contrasting data for the previous year. Also, order intake in comparable terms rose by 15 percent.

In terms of adjusted Ebita (specific parameter that detects operational income), increased by 100 basis points, to 15.8 percent, boosted by improved productivity in the costs and the positive impact of currency exchange.

Frans van Houten, CEO of Philips.
"We are encouraged by the growth of the backlog of 15 percent in 'health care', driven by strong growth in North America, Western Europe and a substantial rebound in China," said Frans van Houten, CEO of Philips.

"Our focus on multi-year strategic partnerships continues to give its fruits as demonstrated in three new agreements based on the integral management of services to optimize the delivery of health care: Mackenzie Health in Canada, the Clinical Hospital of Granada in Spain and Hospices Civils de Lyon France", has been reported.

Consumption and lifestyle
On the other hand, sales of consumption and life style of the company grew by six percent over the previous year, with a growth of double digit in Health & Wellness and a digit unique Personal Care and Domestic Appliances.

"Consumption and life style, once again offered a strong superior performance than expected, with a two digit growth in emerging markets. In India, for example, strong sales of Philips Airfryer, reamers and soupmakers boosted growth to double digits. Oral Healthcare continued its strong track record, with a very solid performance in North America, China, Germany, Austria and Switzerland".

"Lighting showed another year of operational improvements and our portfolio of HealthTech, which combines health care and consumer and life style, business has obtained a promising of more than 4 percent annual comparable sales growth," he stressed.

Innovation and emerging business

"We continue to drive our leadership positions in emerging businesses, such as Digital Pathology and Handheld Diagnostic. For example, Philips and Banyan Biomarcadores signed a joint development agreement to develop and commercialize a new portable blood test to quickly detect traumatic brain injury, such as a concussion", he says.

"The Alliance will expand the application of the Philips portable diagnostic system and strengthen its competitive position in diagnosis at the point of care for acute care, a new and growing market for Philips stays", it added.

The Dutch company Philips earned a net income attributed of EUR 645 million in 2015, representing an increase of 55.4% compared to the previous year, said the multinational.

The turnover of Philips in the whole of the year reached a total of 24.244 million euros, 13.3% more than a year earlier in absolute terms, while comparable values annual turnover grew by 2%.

Among the various units of the company's business, the business of health care rose 19% sales, while consumption unit turnover up 13% and subsidiary lighting 8% more.

However, in the fourth quarter of 2015, Philips recorded losses of 45 million euros, compared to the attributed net profit of 139 million in 2014, due to the impact of exceptional items.

"In general, 2015 was a solid year for Philips," said Frans van Houten, CEO of the multinational, who predicted a "modest growth of comparable sales" by 2016.